CoChat

High prevalence of the G101W germline mutation in the CDKN2A (P16ink4a) gene in 62 Italian malignant melanoma families

Mantelli, Michela, Barile, Monica, Ciotti, Paola, Ghiorzo, Paola, Lantieri, Francesca, Pastorino, Lorenza, Catricalà, Caterina, Torre, Gabriella Della, Folco, Ugo, Grammatico, Paola, Padovani, Laura, Pasini, Barbara, Rovini, Dario, Queirolo, Paola, Rainero, Maria Luisa, Santi, Pier Luigi, Sertoli, Roberto M., Goldstein, Alisa M., Bianchi-Scarrà, Giovanna · 2002 · American Journal of Medical Genetics
Cited by 74

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

CDKN2A germline mutation frequency estimates are commonly based on families with several melanoma cases. When we started counseling in a research setting on gene susceptibility analysis in northern and central Italy, however, we mostly found small families with few cases. Here we briefly characterize those kindred, estimate CDKN2A/CDK4 mutation test yields, and provide indications on the possibility of implementing formal DNA testing for melanoma-prone families in Italy. In September 1995 we started genetic counseling in a research setting at our Medical Genetics Center. Screening for CDKN2A/CDK4 mutations was performed on families with two melanoma patients, one of whom was younger than 50 years at onset, the other complying with one of the following: 1) being a first-degree relative, 2) having an additional relative with pancreatic cancer, or 3) having multiple primary melanomas. Sixty-two of 67 (80%) melanoma cases met our criteria. Four previously described CDKN2A mutations (G101W, R24P, V126D, and N71S) were found in 21 of the 62 families (34%) with a high prevalence of G101W (18/21). The percentage of families with two melanoma cases/family harboring a mutation was low (7%, 2/27), but rose to 45% (9/20) if one of the melanoma patients carried multiple melanomas or if pancreatic cancer was present in that family. In the 15 families with three melanoma cases the presence of a mutation was higher (67%, 10/15) and reached 100% in the 4 families with four or more melanoma cases. Our results suggest that CDKN2A/CDK4 counseling-based mutational analysis may be reasonably efficient also for families with two melanoma cases, if one patient carries multiple melanomas or if pancreatic cancer is present in the family.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ajmg.10135.abs

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 74

Metadata

Authors
Mantelli, M., Barile, M., Ciotti, P., Ghiorzo, P., Lantieri, F., Pastorino, L., Catricalà, C., Torre, G. D., Folco, U., Grammatico, P., Padovani, L., Pasini, B., Rovini, D., Queirolo, P., Rainero, M. L., Santi, P. L., Sertoli, R. M., Goldstein, A. M., & Bianchi-Scarrà, G.
Venue
American Journal of Medical Genetics
Publisher
Wiley
Published
2002-01-22
Volume
107
Issue
3
Pages
214
ISSN
  • 0148-7299 (ISSN-L)
  • 1096-8628
OpenAlex
W4246858996
Cited by
74
References
3
FWCI
3.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High prevalence of the G101W germline mutation in the CDKN2A (P16ink4a) gene in 62 Italian malignant melanoma families. https://app.cochat.ai/papers/10.1002/ajmg.10135.abs
The paper
Mantelli, M., Barile, M., Ciotti, P., Ghiorzo, P., Lantieri, F., Pastorino, L., Catricalà, C., Torre, G. D., Folco, U., Grammatico, P., Padovani, L., Pasini, B., Rovini, D., Queirolo, P., Rainero, M. L., Santi, P. L., Sertoli, R. M., Goldstein, A. M., & Bianchi-Scarrà, G. (2002). High prevalence of the G101W germline mutation in the CDKN2A (P16ink4a) gene in 62 Italian malignant melanoma families. American Journal of Medical Genetics. https://doi.org/10.1002/ajmg.10135.abs

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.